Therapeutic approaches against common structural features of toxic oligomers shared by multiple amyloidogenic proteins.
Biochem Pharmacol
; 88(4): 468-78, 2014 Apr 15.
Article
en En
| MEDLINE
| ID: mdl-24406245
Palabras clave
Amyloid oligomers; Anle138b (http://www.cipsm.de/en/publications/researchAreaA/2013/Anle138b_a_novel_oligomer_modulator_for_disease-modifying_therapy_of_neurodegenerative_diseases_such_as_prion_and_Parkinson_s_disease/index.html?style=1); Anti-amyloid small molecules; Baicalein (PubChem CID: 5281605); CLR01 (http://www.med-chemist.com/2012/11/clr01-effectively-inhibits.html); Curcumin (PubChem CID: 969516); Epigallocatechingallate (PubChem CID: 65064); Immunotherapy; Methylene blue (PubChem CID: 6099); Oleuropein (PubChem CID: 5281544); Phenol Red (PubChem CID: 4766); Resveratrol (PubChem CID: 445154); Silibinin (PubChem CID: 31553)
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Biopolímeros
/
Proteínas Amiloidogénicas
Límite:
Animals
Idioma:
En
Revista:
Biochem Pharmacol
Año:
2014
Tipo del documento:
Article
País de afiliación:
Estados Unidos
Pais de publicación:
Reino Unido